Finally, a Solid Phase Extraction product for Drugs of Abuse

Similar documents
Keep It Clean. Solid Phase Extraction Solutions for Drugs of Abuse Analysis. Neutral Drugs of Abuse Basic Drugs of Abuse

Strata-X- NEW! Drug B. Drug B Plus for In-Well Hydrolysis. Simplify Your Solid Phase Extraction.

PAIN PANEL. Research and Solutions

Protect Your Mass Spec

Rapid Analysis of Synthetic Cannabinoids and their Metabolites in Urine using Solid Phase Extraction and LC/MS/MS. JWH018-4-Hydroxypentyl metabolite

PAIN PANEL. Application Guide. Screen 41 compounds in under 4 minutes

Strata -X Polymeric SPE

Keep it Clean with Strata -X

Labs Across the World Are Advancing Their Protein Precipitation

METHAMPHETAMINE & AMPHETAMINE

Comparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis of Basic Drugs. Table 1. List of pain panel drugs

NEW. Kinetex. Biphenyl TMS TMS TMS TMS. Selectivity that a C18 just can t give you!

APPLICATIONS TN Overview of Kinetex 2.6 µm Core-Shell Technology

APPLICATIONS TN Analytical Method

APPLICATIONS Improving Intact Biogeneric Protein Separations with Aeris WIDEPORE Core-Shell Columns

Phospholipid Removal Solutions

SIMPLIFIED CHIRAL SEPARATIONS. Lux Cellulose-1. Guaranteed Alternative. to CHIRALCEL OD-H. Exceptional Quality Sensibly Priced

APPLICATIONS TN Determination of Sugars in Animal Feed using HPLC-ELSD

APPLICATIONS TN Dramatically Improve Existing 5 µm and 3 µm Fully Porous Methods with Kinetex 5 µm Core-shell Technology.

APPLICATIONS TN A Comparison of Various Kinetex C18 Phases USP: L1

A Fast, Accurate, and Sensitive Quantitiation of Vitamin C in Plasma by Impact Protein Precipitation and Kinetex 5 µm Core-Shell XB-C18 HPLC Columns

High Throughput Extraction of Opiates from Urine and Analysis by GC/MS or LC/MS/MS)

Core-Shell Technology for Proteins and Peptides

APPLICATIONS TN Rapid Analysis of Hop Acids in Beer using Strata -X Solid Phase Extraction and Kinetex 2.6 µm Core-Shell Technology Column

APPLICATIONS TN A Sensitive Extraction Method for Nicotine and Metabolites from Urine using Simplified Liquid Extraction (SLE)

APPLICATIONS TN Materials and Methods

Run 1 Run 2 TDP PLP TDP PLP. 3.0e5 2.8e5 2.2e5. 2.6e5 2.4e5. 2.2e5 2.0e5. Intensity, cps. 1.8e5 1.6e5 1.4e5 1.2e5 1.0e5 4.0e4. 2.0e e5 1.

For Far. Greater. UHPLC Column Performance You Must Have Kinetex Core-Shell UHPLC Columns.

Preparative Chromatography Meets UHPLC

Columns The FIRST and ONLY sub-2 µm core-shell columns on the market

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

Supported Liquid Extraction (SLE) For Food Applications

APPLICATIONS TN µm Core-Shell Particle. (continued on page 2) Page 1 of 8. For additional technical notes, visit

Figure 1. Core-Shell Particle Technology

APPLICATION TN Rapid Analysis of a 48 Drug Research Panel in Less Than 4 Minutes Using Kinetex Biphenyl Core-Shell Technology HPLC/UHPLC Columns

Enantiomeric and Diastereoisomeric Resolutions of Chiral Triazole Fungicides using Lux Polysaccharide-Based Chiral Stationary Phases

Core-Shell Technology. 11 HPLC Myths. Uncovered. & Why You Must Have Kinetex Core-Shell HPLC Columns

Yes You Can! New! Amazing EVO C18. Core-Shell Technology

Confidence. A New Standard of. Calibration, Surrogate, & Internal Standards for Environmental Analysis

Vitamin Testing APPLICATIONS GUIDE

Comparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis of Basic Drugs

APPLICATION TN Materials and Methods Reagents and Chemicals

Workflow for Screening and Quantification of the SAMHSA (NIDA) Panel in Serum Using UHPLC-TOF

Workflow for Screening and Quantification of the SAMHSA (NIDA) Panel in Urine Using UHPLC-TOF

An Easier QuEChERS Solution for Diverse Matrices. Learn more at

TN-0116 Scott Krepich

COMBO ULTIMATE HPLC/UHPLC. Kinetex + Luna Omega NEW. Gain Incredible Performance, Versatile Selectivities and Upgrade Throughput

The Development of LC/MS Methods for Determination of MDMA (Ecstasy) and Metabolites in Biological Samples

APPLICATIONS TN Rapid, High Resolution Analysis of Aflatoxin Extracts from Peanut Butter Using Kinetex Core-Shell Technology and Strata SPE

Exceed your Purification Goals. Guaranteed. Phenomenex l WEB:

Modernizing the Forensic Lab with LC-MS/MS Technology

NeoSal Oral Fluid Collection System Solutions for Forensic Drug Detection

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

LC-MS/MS Method for the Determination of 21 Opiates and Opiate Derivatives in Urine

There's a Cleaner Way!

Awesome! Unconventionally. Kinetex EVO C18 HPLC/UHPLC Core-Shell Columns 2.6. Core-Shell Technology

The Development of LC/MS Methods for Determination of Polar Drugs of Abuse in Biological Samples

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

Urine drug testing it s not always crystal clear

Shuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W

APPLICATIONS TN Determination of Sterols in Olive Oil using Supported Liquid Extraction (SLE), Solid Phase Extraction (SPE) and GC-FID

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

LC-MS/MS Method for the Determination of Tenofovir from Plasma

Overcoming the Challenges of Sample Preparation and LC/MS/MS Method Development for Clinical Applications

The Complete Guide to Solid Phase Extraction (SPE) A method development and application guide

The Drug Testing Process. Employer or Practice

Simultaneous Quantitative Analysis of Total Catecholamines and Metanephrines in Urine Using CLEAN UP CCX2 and LC-MS/MS

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

E XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

Achieving Proposed Federal Concentrations using Reduced Specimen Volume for the Extraction of Amphetamines from Oral Fluid

Validation of an Automated Method to Remove

NEW Kinetex F5. HPLC/UHPLC Core-Shell Columns

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

The Complete Guide to Solid Phase Extraction (SPE) A method development and application guide

Schedule of Accreditation

Aeris. Precision Engineered Core- Shell Particles for Ultra-High Resolution BioSeparations. Aeris PEPTIDE. Aeris WIDEPORE

Providing a Universal, One-step Alternative to Liquid-Liquid Extraction in Bioanalysis

CLINICAL RESEARCH APPLICATIONS GUIDE

UCT STYRE SCREEN INNOVATION THROUGH CHEMISTRY

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

LC Application Note. Dangerous driver?

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

Authors. Abstract. Forensic Toxicology. Irina Dioumaeva, John M. Hughes Agilent Technologies, Inc.

Rapid and Robust Detection of THC and Its Metabolites in Blood

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Laboratory Service Report

Polymeric Sorbents for Sample Preparation

Extraction of 11-nor-9-carboxy-tetrahydrocannabinol from Hydrolyzed Urine by ISOLUTE. SLE+ Prior to GC/MS Analysis

Simultaneous Quantitative Analysis of Total Catecholamines and Metanephrines in Urine Using 500 MG CLEAN UP CCX2 and LC-MS/MS

CANNABIS TESTING ACCESSORIES

Interpretation of Workplace Tests for Cannabinoids

A Novel Platform of On-line Sample Pre-treatment and LC/MS/MS Analysis for Screening and Quantitation of Illicit Drugs in Urine

One Source Toxicology Laboratory, 1213 Genoa Red Bluff, Pasadena, Texas 77504

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Opiates, Opioids and Benzodiazepines, Amphetamines & Illicit Drug Forensic Analysis by LC/MS

New Luna Omega. Columns. The Final Word in Fully Porous UHPLC

Transcription:

n io t c a r t x E e s a h P d li Finally, a So e s u b A f o s g u r D r fo product

Imagine Only Needing 1 SPE Sorbent For All of Your Drugs of Abuse Extractions Extract over 11 drugs using the same sorbent Consolidate methods; 3 methods is all you ll need to extract 6 different drug classes Eliminate multiple purchase orders; you ll never need another sorbent The Solution: Strata-X-Drug B Strata-X-Drug B is a polymeric strong cation-exchange SPE sorbent that is designed and quality controlled with Substance Abuse and Mental Health Services Administration (SAMHSA) regulations in mind. Strata-X-Drug B also Provides: Time and solvent savings; no conditioning required Consistent, high recoveries of SAMHSA regulated drugs Sensitivity at SAMHSA s newly regulated cutoff levels Phenomenex l WEB: www.phenomenex.com

Designed and QC d for Drugs of Abuse What is Special about the QC Process? 1. Recovery tests are performed using everyday samples such as codeine and morphine from urine. 2. Interconversion tests ensure that norcodeine and normorphine are not being converted back to parent compounds, which reduces the risk of false positive results. Strata-X-Drug B Certificate of Analysis We test recovery by extracting codeine and morphine from urine to ensure that each batch provides you with the best results possible! Strong cation-exchange sorbents can sometimes promote conversion of norcodeine and normorphine to parent compounds. Strata-X-Drug B is guaranteed not to promote this interconversion. Phenomenex l WEB: www.phenomenex.com

Reduce Your Extractions to 3 Easy to Follow Methods Condition Opiates, 6-MAM, PCP, and Amphetamines* Marijuana Metabolites Cocaine Metabolites Not Required Load Pre-treated urine sample Pre-treated urine sample Pre-treated urine sample Wash 1 2 ml of 100 mm Sodium acetate buffer (ph 5.0) 2 ml of 100 mm Sodium acetate buffer (ph 5.0) Wash 2 2 ml Methanol 2 ml of Acetonitrile/100 mm Sodium acetate buffer (ph 5.0) (30:70) 2 ml of 0.1 N Hydrochloric acid 2 ml Methanol Dry 10 minutes under full vaccum 15 minutes under full vacuum 10 minutes under full vacuum Elute 1 2 3 2 ml of Ethyl acetate/isopropanol/ Ammonium hydroxide (70:20:10) 2 ml of Ethyl acetate/isopropanol (85:15) * Opiates, 6-MAM, PCP, and Amphetamines can be extracted simultaneously or separately using the same SPE methodology. Methods are written for 60 mg/6 ml Strata-X-Drug B; however they can be scaled to accommodate smaller or larger sample sizes and sorbent masses. 2 ml of Ethyl acetate/isopropanol/ Ammonium hydroxide (70:20:10) And Still Achieve Sensitivity within SAMHSA s Low Cutoff Regulations Drug Class Opiate Metabolites Analyte Codeine Morphine SAMHSA Cutoff 2,000 ng/ml 2,000 ng/ml Strata-X-Drug B % Recovery @ Cutoff 6-MAM 6-Acetylmorphine 10 ng/ml 100.5 PCP Phencyclidine 25 ng/ml 99.33 Amphetamines MDMA Amphetamine Methamphetamine Methylenedioxyamphetamine (MDA) Methylenedioxymethamphetamine (MDMA) Methylenedioxyethylamphetamine (MDEA) Marijuana Metabolites Delta-9-tetrahydrocannabinol-9-carboxylic acid (THCA) 15 ng/ml 99.45 Cocaine Metabolites Benzoylecgonine 100 ng/ml 99.45 99.86 99.80 101.8 97.76 96.65 100.1 102.2 Phenomenex l WEB: www.phenomenex.com

Consistent, Reproducible Results High recoveries are great, but consistency is just as important! Strata-X-Drug B produces high recoveries AND consistent results every time so you can have confidence in your results! Greater than 95 % Recoveries for 11 Drugs of Abuse Consistent, Reproducible Results for 11 Drugs of Abuse Codeine Morphine 6-MAM Phencyclidine Amphetamine Methamphetamine MDA MDMA 99.86 % 99.80 % 100.50 % 99.33 % 101.80 % 97.76 % 96.65 % 100.10 % Analyte RSD % (N=3) Linearity Codeine 0.43 0.999 Morphine 0.59 0.999 6-MAM 0.63 0.999 Phencyclidine 0.63 0.999 Amphetamine 1.59 0.997 Methamphetamine 1.99 0.998 MDA 3.03 0.995 MDMA 1.20 0.998 MDEA 1.93 0.999 Carboxy-THC 0.95 0.999 Benzoylecgonine 0.95 0.999 MDEA 102.20 % Carboxy-THC 99.45 % Benzoylecgonine 99.45 % 0 20 40 60 80 100 Relative Recovery (%) Phenomenex l WEB: www.phenomenex.com

Confirm Your Recoveries and Cleanliness Once your extractions are completed, achieve excellent separation of target analytes with Kinetex Core-Shell LC columns or Zebron GC columns. Kinetex Core-Shell LC Columns Leverage the power of Kinetex to achieve ultra-high performance on any LC system. Increase resolution, throughput, and sensitivity Decrease solvent consumption Save time and money Transfer methods anywhere Visit www.phenomenex.com/kinetex for more information Zebron High Performance ZB-Drug-1 GC Column Achieve highly reproducible and effective separation of drugs of abuse while capitalizing on speed and efficiency. Decrease run times Improve resolution and sensitivity Increase lab productivity and profitability Visit www.phenomenex.com/zebron for more information For specific applications, download Technical Note TN-0041, A Simplified and Streamlined Approach to Solid Phase Extraction using Strata-X-Drug B for SAMHSA s Low Cutoff Drugs of Abuse Panel www.phenomenex.com/strata-x OR Search our application library at www.phenomenex.com/application Phenomenex l WEB: www.phenomenex.com

Start Saving Time and Money Today! Ordering Information Strata-X-Drug B Format Sorbent Mass Part Number Unit Price Tube 10 mg 8B-S128-AAK 1 ml (100/box) 10 mg 8L-S128-AAK 1 ml (100/box) 30 mg 8B-S128-TAK 1 ml (100/box) 30 mg 8L-S128-TAK 1 ml (100/box) 30 mg 8B-S128-TBJ 3 ml (50/box) 60 mg 8B-S128-UBJ 3 ml (50/box) 60 mg 8B-S128-UCH 6 ml (30/box) 60 mg 8B-S128-UCL 6 ml (200/box) Giga Tube 100 mg 8B-S128-EDG 12 ml (20/box) 96-Well Plate 10 mg 8E-S128-AGB 2 Plates/box 30 mg 8E-S128-TGB 2 Plates/box 60 mg 8E-S128-UGB 2 Plates/box Tab-less tube Zebron ZB-Drug-1 GC Columns ID (mm) df (µm) Temp. Limits C Part No. Price 10-Meter 0.18 0.18 40 to 320/340 C 7CD-G023-08 15-Meter 0.25 0.25 40 to 320/340 C 7EG-G023-11 30-Meter 0.25 0.25 40 to 320/340 C 7HG-G023-11 Kinetex 2.6 μm Analytical Columns (mm) 30 x 4.6 50 x 4.6 75 x 4.6 100 x 4.6 150 x 4.6 XB-C18 00B-4496-E0 00C-4496-E0 00D-4496-E0 00F-4496-E0 C18 00A-4462-E0 00B-4462-E0 00C-4462-E0 00D-4462-E0 00F-4462-E0 C8 00B-4497-E0 00C-4497-E0 00D-4497-E0 00F-4497-E0 PFP 00A-4477-E0 00B-4477-E0 00C-4477-E0 00D-4477-E0 00F-4477-E0 Kinetex 2.6 μm MidBore Columns (mm) 30 x 3.0 50 x 3.0 75 x 3.0 100 x 3.0 150 x 3.0 XB-C18 00B-4496-Y0 00D-4496-Y0 C18 00A-4462-Y0 00B-4462-Y0 00C-4462-Y0 00D-4462-Y0 00F-4462-Y0 C8 00B-4497-Y0 00D-4497-Y0 PFP 00A-4477-Y0 00B-4477-Y0 00C-4477-Y0 00D-4477-Y0 00F-4477-Y0 Kinetex 2.6 μm Minibore Columns (mm) 30 x 2.1 50 x 2.1 100 x 2.1 150 x 2.1 If Phenomenex products in this brochure do not provide at least an equivalent separation as compared to other products of the same phase and comparable dimensions, send in your comparative data within 45 days and keep the product for FREE. XB-C18 00A-4496-AN 00B-4496-AN 00D-4496-AN 00F-4496-AN C18 00A-4462-AN 00B-4462-AN 00D-4462-AN 00F-4462-AN C8 00A-4497-AN 00B-4497-AN 00D-4497-AN 00F-4497-AN PFP 00A-4477-AN 00B-4477-AN 00D-4477-AN 00F-4477-AN Kinetex 1.7 μm Minibore Columns (mm) 50 x 2.1 100 x 2.1 150 x 2.1 XB-C18 00B-4498-AN 00D-4498-AN C18 00B-4475-AN 00D-4475-AN 00F-4475-AN C8 00B-4499-AN 00D-4499-AN PFP 00B-4476-AN 00D-4476-AN 00F-4476-AN Terms and Conditions Subject to Phenomenex Standard Terms & Conditions, which may be viewed at www.phenomenex.com/termsandconditions. Trademarks Kinetex is a registered trademark of Phenomenex, Inc. in the United States, European Union, and other jurisdictions. Strata-X, Giga, MidBore, and Zebron are trademarks of Phenomenex, Inc. Strata-X is patented by Phenomenex, Inc. U.S. Patent No. 7,119,145 2011 Phenomenex, Inc. All rights reserved. Phenomenex l WEB: www.phenomenex.com

BR82590910_I Australia t: 02-9428-6444 f: 02-9428-6445 auinfo@phenomenex.com Austria t: 01-319-1301 f: 01-319-1300 anfrage@phenomenex.com Belgium t: +31 (0)30-2418700 f: +31 (0)30-2383749 beinfo@phenomenex.com Canada t: (800) 543-3681 f: (310) 328-7768 info@phenomenex.com Denmark t: 4824 8048 f: 4810 6265 nordicinfo@phenomenex.com Finland t: (09)4789 0063 f: +45 4810 6265 nordicinfo@phenomenex.com France t: 01 30 09 21 10 f: 01 30 09 21 11 franceinfo@phenomenex.com Germany t: 06021-58830-0 f: 06021-58830-11 anfrage@phenomenex.com Ireland t: 01 247 5405 f: +44 1625-501796 eireinfo@phenomenex.com Italy t: 051 6327511 f: 051 6327555 italiainfo@phenomenex.com Luxembourg t: +31 (0)30-2418700 f: +31 (0)30-2383749 nlinfo@phenomenex.com Mexico t: (55) 5018 3791 f: (310) 328-7768 tecnicomx@phenomenex.com The Netherlands t: 030-2418700 f: 030-2383749 nlinfo@phenomenex.com New Zealand t: 09-4780951 f: 09-4780952 nzinfo@phenomenex.com Norway t: 810 02 005 f: +45 4810 6265 nordicinfo@phenomenex.com Puerto Rico t: (800) 541-HPLC f: (310) 328-7768 info@phenomenex.com United Kingdom t: 01625-501367 f: 01625-501796 ukinfo@phenomenex.com All other countries: Corporate Office USA t: (310) 212-0555 f: (310) 328-7768 info@phenomenex.com www.phenomenex.com Phenomenex products are available worldwide. For the distributor in your country, contact Phenomenex USA, International Department at international@phenomenex.com